CBD Life Sciences Inc. $CBDL Reports over 1,000% Revenue Increase from its Online Sales from January to June 2026
Generated six-month revenue growth equivalent to an annualized rate of over 4,000%, capitalizing on accelerating demand in the CBD and Mushroom Supplement Markets, forecasted to reach a combined $45 billion by 2028.
SCOTTSDALE, AZ / June 30, 2026 / CBD Life Sciences Inc. (OTC PINK:CBDL), an emerging leader in the natural health and wellness industry, is pleased to announce a 1,000% increase in revenue from January through June 2026, marking a record-breaking milestone for the company and highlighting the success of its expanding retail, e-commerce, and direct-to-consumer distribution strategy.
The exceptional performance represents the strongest sustained month-over-month revenue growth in the company's history and reflects CBDL's successful evolution from a CBD-focused business into a diversified wellness brand. Today, the company offers an expanding portfolio of innovative products designed to support performance, recovery, cognitive health, and overall well-being.
"This achievement represents far more than increased sales—it's evidence that CBDL is becoming a trusted wellness brand consumers actively seek out," said Lisa Nelson, President & CEO of CBD Life Sciences Inc. "By focusing on product innovation, expanding consumer access, and building a recognizable brand in the functional wellness market, we've established a scalable foundation for long-term, sustainable growth."
Key Drivers Of Growth
National Retail Expansion & E-Commerce Ubiquity
CBDL's omnichannel retail strategy has been a key driver of growth in 2026, expanding the brand's presence across leading digital marketplaces and consumer platforms where customers actively shop. Recent distribution milestones include:
Walmart Marketplace: Expanded online product availability with multiple SKUs, including CBDL's top-selling 3000MG Pain Relief Cream and premium skincare formulations
• DoorDash & Leafly: Increased accessibility through on-demand local delivery in select markets, providing customers with greater convenience and faster fulfillment.
• Groupon: Leveraged targeted promotional campaigns and limited-time wellness offers to drive first-time customer acquisition and increase brand visibility.
• Shopify & Reddit: Strengthened direct-to-consumer sales through Shopify while building brand awareness and customer engagement within Reddit's wellness-focused communities.
Product Innovation: Functional Wellness for the Modern Consumer
CBDL's revenue growth closely aligns with its rapid innovation across plant-powered health categories. Our Top Selling Products are listed below.
• CBD Pain Relief Cream offers targeted relief with potent concentrations of 3000mg and 8000mg in convenient 1.7oz and 8oz sizes. Formulated to soothe discomfort and support recovery, this cream absorbs quickly to deliver effective, localized pain management. Ideal for those seeking expert-grade relief, it combines strength and ease of use for daily wellness support.
• Experience quick and effective relief with our CBD Pain-Relief Roll-On Gel. Infused with premium CBD extract, this roll-on gel is designed to target sore muscles and joints, providing a cooling sensation and soothing comfort exactly where you need it.
• Elevate your wellness routine with our Full-Spectrum CBD Drops, available in a variety of flavors: Bubba Kush, StrawÂnana and Unflavored. Crafted with high-quality cannabidiol (CBD), these drops offer a convenient and delicious way to incorporate the benefits of CBD into your daily life.
Dubai Mushroom Chocolate is infused with carefully selected functional mushroom extracts, this chocolate is designed to support focus, mood, and overall well-being—without sacrificing flavor. Each bite melts effortlessly, offering a refined chocolate profile with subtle earthy undertones that feel indulgent, not overpowering.
Strategic Vision & Responsible Growth
CBDL continues to invest in its operational infrastructure, brand development, and strategic partnerships to support long-term, sustainable growth. As the company strengthens its position in the U.S. market, it is also evaluating additional retail partnerships and future expansion opportunities designed to broaden its market reach and enhance shareholder value.
"Our priority is to deliver high-quality wellness products through trusted, accessible retail channels while continuing to build meaningful relationships with our customers," said Lisa Nelson, President & CEO of CBD Life Sciences Inc. "As we execute our long-term growth strategy, we remain committed to responsible expansion, product innovation, and creating lasting value for both consumers and our shareholders."
About CBD Life Sciences Inc. (CBDL)
CBD Life Sciences Inc. is an Arizona-based health and wellness company dedicated to developing and marketing premium wellness products that support today's active lifestyles. Its growing portfolio includes formulations designed to promote pain relief, stress management, restful sleep, inflammation support, cognitive wellness, and overall well-being. Guided by a commitment to quality, transparency, innovation, and consumer accessibility, CBDL continues to expand its product offerings while building a trusted brand in the rapidly evolving health and wellness marketplace.
Follow our social media for the latest updates!
Instagram: https://www.instagram.com/cbd.vault
IR Contact: cbdvaultaz@gmail.com
Website: www.mushroommadness.shop
Forward-Looking Statements
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc.'s, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.
Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements.
Contact Information
Lisa Nelson
CEO
(480) 209-1720
SOURCE:Â CBD Life Sciences Inc.
Comments